Carol Giltner Gallagher, Director at Atara Biotherapeutics, Inc. (ATRA), bought 11,000 shares at $18.00 ($198K) on 2015-02-18, disclosed to the SEC on 2015-02-18.
Open-market purchase of $198k ATRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2018-06-19 | $112K | — | Filing → |
| ATRA | SELL | 2018-05-16 | $13K | — | Filing → |
| ATRA | SELL | 2018-02-20 | $110K | — | Filing → |